MR Share Price

Open 27.85 Change Price %
High 27.95 1 Day 0.07 0.25
Low 27.85 1 Week 0.00 0.00
Close 27.94 1 Month 0.00 0.00
Volume 323675 1 Year 1.02 3.79
52 Week High 27.95
52 Week Low 26.18
MR Important Levels
Resistance 2 28.03
Resistance 1 27.99
Pivot 27.91
Support 1 27.89
Support 2 27.85
NYSE USA Most Active Stocks
BAC 21.23 -1.26%
BAC 21.23 -1.26%
BAC 21.23 -1.26%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
WSH 47.18 -2.86%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
VNR 0.91 19.74%
VNR 0.91 19.74%
P 13.33 16.11%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Mindray Medical International Limited (NYSE: MR)

MR Technical Analysis 4
As on 3rd Mar 2016 MR Share Price closed @ 27.94 and we RECOMMEND Buy for LONG-TERM with Stoploss of 26.86 & Strong Buy for SHORT-TERM with Stoploss of 27.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
MR Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
MR Other Details
Segment EQ
Market Capital 3691241728.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.mindray.com
MR Address
MR
Mindray Building
Keji 12th Road South
Shenzhen, 518057
China
Phone: 86 755 8188 8666
Fax: 86 755 2658 2500
MR Latest News
Follow The Earnings: Analysis and Mindray Medical International Ltd (ADR) (MR ...   MoneyMakingArticles   - 14th Nov 16
Earnings in Focus: Mindray Medical International Ltd (ADR) (MR)   CWRU Observer   - 05th Mar 16
TCF Financial Corporation (TCB): Hedge Funds Are Snapping Up   Insider Monkey (blog)   - 30th Nov 15
US-Listed China Firms Hurry Homeward   Wall Street Journal   - 18th Nov 15
Mindray Medical (MR) Q3 Earnings Beat, Revenues Improve   Zacks.com   - 16th Nov 15
Mindray Medical Receives Reduced Management Buyout Proposal   Wall Street Journal   - 10th Sep 15
Research and Markets: Leading 100 Global Medical Devices Companies 2015   Business Wire (press release)   - 23rd Mar 15
What Hedge Funds Think About Mindray Medical International Ltd (ADR) (MR)   Insider Monkey (blog)   - 12th Sep 13
Should You Avoid Mindray Medical International Ltd (ADR) (NYSE:MR)?   Insider Monkey (blog)   - 12th Apr 13
4 Chinese Healthcare Stocks to Consider   Seeking Alpha   - 07th Nov 10
Interactive Technical Analysis Chart Mindray Medical International Limited ( MR NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Mindray Medical International Limited
MR Business Profile
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. Its markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, The People’s Republic of China.